Tarsons Products Limited is an interesting proxy to healthcare where in it manufactures plastic labware for lab research, diagnostic centres etc. Plastic labware is like ‘pick & shovel’ for the lab research segments like CRAMS, diagnostics, government research. Idea is to gain indirect exposure to the pharma research industry by investing in suppliers. Company is undergoing a significant capex cycle which not only increases its revenue potential but also help company foray into high margin lab product lines. As the new plant is expected to operationalize in Q4 FY25, company can witness pickup of growth in FY26.
first published: Dec 5, 2024 08:03 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty holds gain for 4th day, above 25,100 on weekly expiry day | Closing bell
Zoho CEO Mani Vembu On Why India Needs Arattai, Growth Surge And Integrating Businesses | Exclusive
LG Electronics’ Rs 11,607 Cr IPO Opens; Management Charts Out the Road Ahead | IPO Watch Live
Live: Can bulls extend Nifty's rally to the fourth straight day? | Opening Bell
You are already a Moneycontrol Pro user.